MedPath

Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)

Phase 4
Recruiting
Conditions
Lateral Epicondylitis
Tennis Elbow
Interventions
Procedure: Lateral Epicondylectomy
Biological: Smith & Nephew Bioinductive Implant
Radiation: Ultrasound Imaging
Registration Number
NCT03718637
Lead Sponsor
Henry Ford Health System
Brief Summary

The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Detailed Description

A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non surgery options for 6 months (physical therapy, lifestyle changes, anti-inflammatories, injections) Patients in the "control group" will receive the standard surgery (open lateral epicondylectomy) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Diagnosis of lateral epicondylitis (tennis elbow) that has failed conservative treatment (Physical therapy, activity change, anti-inflammatory treatment.
Exclusion Criteria
  • Previous surgery on the currently-affected elbow.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlLateral EpicondylectomySurgical treatment alone, consisting of tendon debridement and repair. Ultrasounds preoperatively and 6 months postoperatively.
ExperimentalUltrasound ImagingIdentical surgical treatment plus Smith \& Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.
ExperimentalSmith & Nephew Bioinductive ImplantIdentical surgical treatment plus Smith \& Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.
ExperimentalLateral EpicondylectomyIdentical surgical treatment plus Smith \& Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.
ControlUltrasound ImagingSurgical treatment alone, consisting of tendon debridement and repair. Ultrasounds preoperatively and 6 months postoperatively.
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale (VAS) for PainPreoperative to 1 year postoperative

Traditional 1 to 10, subjective rating of pain the patient is experiencing

PROMIS CAT ScoresPreoperative to 1 year postoperative

A short 5 minute survey asking questions about physical function, pain, and mental health

Range of MotionPreoperative to 1 year

Standard range of motion values collected by the surgeon during preoperative and followup visits

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath